ChiCTR2000028765
结束
/
/
/
2020-01-02
/
/
Proximal femoral fracture
Reverse oblique intertrochanteric fractures fixation
Proximal femoral locking compression plate: Better fracture reduction quality and similar functional results compared to long proximal femoral nail antirotation in fixation of reverse oblique intertrochanteric fractures
The aim of this study was to compare the clinical and radiological results of long proximal femoral nail antirotation (LPFNA) with proximal femoral locking compression plate (PFLCP) in fixation of reverse oblique fractures.
非随机对照试验
回顾性研究
No
No
we have not any funding
/
35;27
/
2018-11-25
2019-02-25
/
Our inclusion criteria were; age over 18 who has no deformity and previus fracture with same extremity；
请登录查看Our exclusion criteria were as follow: age <18 years, AO/OTA 31A1 and 31A2 fractures, fractures that extended 10 cm distal to the level of the lesser trochanter, bilateral hip fracture, pathologic fractures, another fracture in the extremities or spine, open fractures, history of lower limb fracture or deformity, previous ipsilateral lower limb surgery, contralateral hip fracture within the last year, cognitive impairment, severe concomitant medical condition (Grade V American Society of Anesthesiologists [ASA] score) [12]. death during follow-up, reoperation requirements due to mechanical complications, and a follow-up period of <1 year.；
请登录查看Orthopaedics and taumatology clinic (MD MEHMET ALI TALMAC)
/
Orthopaedics and taumatology clinic (MD MEHMET ALI TALMAC)的其他临床试验
土耳其伊斯坦布尔锡斯利哈米迪耶埃法尔医院的其他临床试验
最新临床资讯
-
大鹏制药临床III期成功
新药说2026-08-13
-
新一代 EGFR-TKI 首个全球 III 期成功
丁香园 Insight 数据库2026-08-13
-
体外诊断原料网2026-08-13
-
佰傲谷BioValley2026-08-13
-
久有基金2026-08-13
-
重庆宸安生物2026-08-13
-
UmabsDB2026-08-13
-
希格生科2026-08-13
-
bioSeedin柏思荟2026-08-13
-
智飞智讯2026-08-13
全球药物研发中心
全球研发数据与行业前沿情报
研发动态
相关报告
政策法规
-
2026-08-13
-
2026-08-13
-
2026-08-13
-
摩熵咨询 20 8
-
摩熵咨询 34 28
-
摩熵咨询 20 5
-
颁布机构：四川省经济和信息化厅、中共四川省委军民融合发展委员会办公室、四川省教育厅、四川省科学技术厅、四川省人力资源和社会保障厅、四川省卫生健康委员会、四川省医疗保障局、四川省中医药管理局、四川省药品监督管理局 2026-08-04
-
颁布机构：国家医保局 2026-07-31
-
颁布机构：国家药品审评中心（CDE） 2026-07-24
医药市场洞察中心
医药市场销售数据分析 · 智能洞察 · 竞争格局监测
-
医药市场销售数据分析 · 医院、实体药店、网上药店
-
市场竞争格局分析(靶点、药品类型、ATC大类)
市场动态
市场报告
政策法规
-
2026-08-13
-
2026-08-13
-
2026-08-13
-
摩熵咨询 35 36
-
摩熵咨询 28 39
-
摩熵咨询 34 18
-
颁布机构：国家市场监督管理总局 2026-08-10
-
颁布机构：国家市场监督管理总局 2026-05-29
-
颁布机构：国家市场监督管理总局 2026-05-29